Vincristine 57-22-7 CAS NO.57-22-7
- FOB Price: USD: 800.00-1,000.00 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: D/A,D/P,T/T,
- Available Specifications:
99%(1-100)Gram99%(101-200)Gram
- Product Details
Keywords
- vincristine
- 57-22-7
- C46H56N4O10
Quick Details
- ProName: Vincristine 57-22-7
- CasNo: 57-22-7
- Molecular Formula: C46H56N4O10
- Appearance: Solid powder
- Application: Applied in dietary supplements,pharmac...
- DeliveryTime: prompt
- PackAge: Foil bag or drum
- Port: Shanghai
- ProductionCapacity: 5000 Kilogram/Month
- Purity: 99% BY HPLC
- Storage: Sealed,light and oxygen resistant
- Transportation: by sea or air
- LimitNum: 1 Gram
- Grade: Pharma Grade,Other
Superiority
Vincristine
CAS:2068-78-2
Specification:USP
Assay:99%
Appearance:white powder
Details
Vincristine
CAS:2068-78-2
Specification:USP
Assay:99%
Appearance:white powder
XI'AN KONO CHEM (XI'AN KONO CHEM) is a commitment to the development of pharmaceutical raw materials and intermediates in the production, management and plant extracts of the export trade suppliers in recent years, it and other Asian countries and Europe, the Americas, African countries have trade, our goal is to become an important domestic pharmaceutical and chemical raw materials exporters and the world's latest pharmaceutical raw materials importers.
Xi'an Connaught Chemical has been adhering to the company to market-oriented, customer-focused, with professional and enterprising spirit of the team and the company's strong financial strength, to provide customers with fast, high quality and efficient services, and always to "maximize Interests of customers "for the purpose.
In the pharmaceutical raw materials and intermediate export business, the company with more than 10 years of accumulated experience and high-quality and reasonable personnel structure, accurate grasp of the market, not only with a number of well-known domestic enterprises to establish a long-term and stable strategic cooperative relations in the global pharmaceutical Chemical raw materials and chemical intermediates on the market has also won a loyal customer base and a very strong strategic cooperation partners, establish a professional image of the procurement of medical outsourcing. On the basis of continuing to develop existing export business, the Company has formulated the idea of establishing an independent R & D center and building a production base of pharmaceutical and chemical products according to the future development trend of the pharmaceutical and chemical industry, and strives to establish a combination of R & D, manufacturing and trade. Of the business development model.